Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
SeaSpine to Present at the Cantor Fitzgerald Healthcare Conference
-
Perrigo Co. (PRGO) PT Raised to $107 at Cantor Fitzgerald Following Meetings with CEO & CFO: Upside Potential to 2H17 Earnings from CHCI & Rx Operating Margins
-
UPDATE: Cantor Remains Negative On Intercept Pharma (ICPT)
-
HealthEquity to Present at Conferences in September
-
VBI Vaccines to Present at September 2017 Investor Conferences
-
TransEnterix to Participate in Two Upcoming Healthcare Conferences
-
Cantor Fitzgerald Remains Bullish on Horizon Pharma (HZNP) After Adjusting Estimates
-
Retrophin to Present at September Investor Conferences
-
/C O R R E C T I O N -- Protagonist Therapeutics, Inc./
-
Protagonist Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Arrowhead to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
-
Health Insurance Innovations (HIIQ) Defended at Cantor Fitzgerald
-
Shelters to Shutters to Participate in 2017 Cantor Fitzgerald Charity Day
-
Teva Pharma (TEVA): New CEO Is Good News For Teva - Cantor
-
Vital Therapies Announces Recent and Upcoming Scientific Presentations and Participation in Upcoming Investor Conference
-
Array Biopharma (ARRY): Bigger Market for Bini/Enco - Cantor
-
Impax Laboratories (IPXL): Raising PT - Cantor
-
AxoGen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Teva Pharma (TEVA) PT Lowered to $17 at Cantor Fitzgerald
-
All Hands Volunteers to Participate in 2017 Cantor Fitzgerald Charity Day
-
BGC Partners Completes Acquisition of Berkeley Point
-
NewLink Genetics (NLNK): Cutting PT to $26 PT After Positive Updated Phase II Indoximod Data - Cantor
-
Nicox first half 2017 business and financial update
-
Intellia Therapeutics to Present at Upcoming September Investor Healthcare Conferences
-
TherapeuticsMD (TXMD) Gains as Analysts Cover Call from WHI-OS Co-Author
-
Kamada to Present Corporate Overview at Two Investor Conferences in September
-
Flex Pharma Presenting at Upcoming Investor Conferences in September 2017
-
VolitionRx Limited to Attend Multiple Conferences in September
-
AcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events in September
-
Ocular Therapeutix™ to Present at Three Upcoming Investor Conferences
-
Cantor Fitzgerald Upgrades Verastem (VSTM) to Overweight
-
Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences
-
Aimmune Therapeutics to Participate in Three Investor Conferences in September
-
Aerie Pharmaceuticals to Present at Two Investor Conferences in September
-
PDL BioPharma to Present at Two Upcoming Investor Conferences
-
Asterias Biotherapeutics to Present at Upcoming Conferences
-
Collegium to Present at Upcoming Investor Conferences
-
TherapeuticsMD to Present at Two Upcoming Investor Conferences
-
Eagle Pharmaceuticals, Inc. to Present at September Investor Conferences
-
Egalet to Present at Investor Conferences this Fall
-
DURECT to Participate in Upcoming Healthcare Conferences
-
Allscripts to present at upcoming investor events
-
LeMaitre Vascular to Present at Upcoming Investor Conferences
-
Cytokinetics to Present at September Investor Conferences
-
ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences
-
Akebia to Present at Upcoming Investor Conferences
-
ChemoCentryx to Present at Three Upcoming Investor Conferences
-
Keryx Biopharmaceuticals to Webcast its Presentations at Investor Healthcare Conferences in September 2017
-
BioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences

